Manipulating the natriuretic peptide system for the treatment of pulmonary hypertension

類似資料

• Enhancing natriuretic peptide bioactivity prevents bleomycin-induced pulmonary fibrosis
  著者:: Baliga, Reshma S, 等
  出版事項: (2011)
• Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis
  著者:: Baliga, R S, 等
  出版事項: (2014)
• New perspectives for the treatment of pulmonary hypertension
  著者:: Baliga, Reshma S, 等
  出版事項: (2011)
• Synergy between Natriuretic Peptides and Phosphodiesterase 5 Inhibitors Ameliorates Pulmonary Arterial Hypertension
  著者:: Baliga, Reshma S., 等
  出版事項: (2008)
• Inhibition of Phosphodiesterase 2 Augments cGMP and cAMP Signaling to Ameliorate Pulmonary Hypertension
  著者:: Bubb, Kristen J, 等
  出版事項: (2014)